Mangalam Global Enterprise Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 9:08 am

Competitors of Mangalam Global Enterprise Ltd

All Competitor Stocks of Mangalam Global Enterprise Ltd

Quarterly Result

Last Updated: August 1, 2025, 5:25 pm

Below is a detailed analysis of the quarterly data for Mangalam Global Enterprise Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 858.54 Cr.. The value appears strong and on an upward trend. It has increased from 536.73 Cr. (Mar 2025) to 858.54 Cr., marking an increase of 321.81 Cr..
• For Expenses, as of Jun 2025, the value is 845.98 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 528.94 Cr. (Mar 2025) to 845.98 Cr., marking an increase of 317.04 Cr..
• For Operating Profit, as of Jun 2025, the value is 12.56 Cr.. The value appears strong and on an upward trend. It has increased from 7.79 Cr. (Mar 2025) to 12.56 Cr., marking an increase of 4.77 Cr..
• For OPM %, as of Jun 2025, the value is 1.46%. The value appears strong and on an upward trend. It has increased from 1.45% (Mar 2025) to 1.46%, marking an increase of 0.01%.
• For Other Income, as of Jun 2025, the value is 4.18 Cr.. The value appears to be declining and may need further review. It has decreased from 6.66 Cr. (Mar 2025) to 4.18 Cr., marking a decrease of 2.48 Cr..
• For Interest, as of Jun 2025, the value is 7.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.21 Cr. (Mar 2025) to 7.65 Cr., marking an increase of 1.44 Cr..
• For Depreciation, as of Jun 2025, the value is 0.62 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.63 Cr. (Mar 2025) to 0.62 Cr., marking a decrease of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 8.47 Cr.. The value appears strong and on an upward trend. It has increased from 7.61 Cr. (Mar 2025) to 8.47 Cr., marking an increase of 0.86 Cr..
• For Tax %, as of Jun 2025, the value is 24.09%. The value appears to be improving (decreasing) as expected. It has decreased from 31.80% (Mar 2025) to 24.09%, marking a decrease of 7.71%.
• For Net Profit, as of Jun 2025, the value is 6.43 Cr.. The value appears strong and on an upward trend. It has increased from 5.19 Cr. (Mar 2025) to 6.43 Cr., marking an increase of 1.24 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.20. The value appears strong and on an upward trend. It has increased from 0.16 (Mar 2025) to 0.20, marking an increase of 0.04.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:54 am

Balance Sheet

Last Updated: November 9, 2025, 2:28 pm

Below is a detailed analysis of the balance sheet data for Mangalam Global Enterprise Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 33.00 Cr..
• For Reserves, as of Sep 2025, the value is 193.00 Cr.. The value appears strong and on an upward trend. It has increased from 169.00 Cr. (Mar 2025) to 193.00 Cr., marking an increase of 24.00 Cr..
• For Borrowings, as of Sep 2025, the value is 234.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 224.00 Cr. (Mar 2025) to 234.00 Cr., marking an increase of 10.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 130.00 Cr. (Mar 2025) to 276.00 Cr., marking an increase of 146.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 736.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 556.00 Cr. (Mar 2025) to 736.00 Cr., marking an increase of 180.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Investments, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Other Assets, as of Sep 2025, the value is 677.00 Cr.. The value appears strong and on an upward trend. It has increased from 496.00 Cr. (Mar 2025) to 677.00 Cr., marking an increase of 181.00 Cr..
• For Total Assets, as of Sep 2025, the value is 736.00 Cr.. The value appears strong and on an upward trend. It has increased from 556.00 Cr. (Mar 2025) to 736.00 Cr., marking an increase of 180.00 Cr..

However, the Borrowings (234.00 Cr.) are higher than the Reserves (193.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Mangalam Global Enterprise Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 2.00 (Mar 24) to 1.00, marking a decrease of 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 5. It has decreased from 1.40 (Mar 24) to 0.72, marking a decrease of 0.68.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 5. It has decreased from 1.40 (Mar 24) to 0.72, marking a decrease of 0.68.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 3. It has decreased from 1.61 (Mar 24) to 0.77, marking a decrease of 0.84.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.12. It has decreased from 9.63 (Mar 24) to 6.12, marking a decrease of 3.51.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.12. It has decreased from 9.63 (Mar 24) to 6.12, marking a decrease of 3.51.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 69.23. It has decreased from 127.53 (Mar 24) to 69.23, marking a decrease of 58.30.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 2.00. This value is within the healthy range. It has decreased from 3.42 (Mar 24) to 2.00, marking a decrease of 1.42.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 3.21 (Mar 24) to 1.93, marking a decrease of 1.28.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.95. This value is within the healthy range. It has decreased from 1.57 (Mar 24) to 0.95, marking a decrease of 0.62.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 2. It has decreased from 1.40 (Mar 24) to 0.70, marking a decrease of 0.70.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 2. It has decreased from 1.40 (Mar 24) to 0.70, marking a decrease of 0.70.
• For PBDIT Margin (%), as of Mar 25, the value is 2.88. This value is below the healthy minimum of 10. It has increased from 2.68 (Mar 24) to 2.88, marking an increase of 0.20.
• For PBIT Margin (%), as of Mar 25, the value is 2.78. This value is below the healthy minimum of 10. It has increased from 2.51 (Mar 24) to 2.78, marking an increase of 0.27.
• For PBT Margin (%), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 10. It has increased from 1.23 (Mar 24) to 1.37, marking an increase of 0.14.
• For Net Profit Margin (%), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 5. It has decreased from 1.09 (Mar 24) to 1.01, marking a decrease of 0.08.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 8. It has decreased from 1.09 (Mar 24) to 1.01, marking a decrease of 0.08.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.46. This value is below the healthy minimum of 15. It has decreased from 14.55 (Mar 24) to 11.46, marking a decrease of 3.09.
• For Return on Capital Employeed (%), as of Mar 25, the value is 28.47. This value is within the healthy range. It has increased from 25.92 (Mar 24) to 28.47, marking an increase of 2.55.
• For Return On Assets (%), as of Mar 25, the value is 4.15. This value is below the healthy minimum of 5. It has decreased from 4.81 (Mar 24) to 4.15, marking a decrease of 0.66.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.26 (Mar 24) to 0.08, marking a decrease of 0.18.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.11. This value exceeds the healthy maximum of 1. It has decreased from 1.45 (Mar 24) to 1.11, marking a decrease of 0.34.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 4.68. It has increased from 4.28 (Mar 24) to 4.68, marking an increase of 0.40.
• For Current Ratio (X), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 1.5. There is no change compared to the previous period (Mar 24) which recorded 1.46.
• For Quick Ratio (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has increased from 1.02 (Mar 24) to 1.14, marking an increase of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 21.76. This value exceeds the healthy maximum of 8. It has increased from 21.05 (Mar 24) to 21.76, marking an increase of 0.71.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 1.42.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 20. It has increased from 1.24 (Mar 24) to 1.29, marking an increase of 0.05.
• For Earning Retention Ratio (%), as of Mar 25, the value is 98.58. This value exceeds the healthy maximum of 70. There is no change compared to the previous period (Mar 24) which recorded 98.58.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.71. This value exceeds the healthy maximum of 70. It has decreased from 98.76 (Mar 24) to 98.71, marking a decrease of 0.05.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 3. It has increased from 1.94 (Mar 24) to 2.21, marking an increase of 0.27.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.86. This value is below the healthy minimum of 3. It has increased from 1.73 (Mar 24) to 1.86, marking an increase of 0.13.
• For Enterprise Value (Cr.), as of Mar 25, the value is 708.79. It has increased from 470.05 (Mar 24) to 708.79, marking an increase of 238.74.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.31, marking an increase of 0.06.
• For EV / EBITDA (X), as of Mar 25, the value is 10.78. This value is within the healthy range. It has increased from 9.53 (Mar 24) to 10.78, marking an increase of 1.25.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. It has increased from 0.15 (Mar 24) to 0.21, marking an increase of 0.06.
• For Retention Ratios (%), as of Mar 25, the value is 98.57. This value exceeds the healthy maximum of 70. There is no change compared to the previous period (Mar 24) which recorded 98.57.
• For Price / BV (X), as of Mar 25, the value is 2.48. This value is within the healthy range. It has increased from 2.04 (Mar 24) to 2.48, marking an increase of 0.44.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. It has increased from 0.15 (Mar 24) to 0.21, marking an increase of 0.06.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.04, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness